Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 2, 2003, Pages 709-717

  Rashid, Md Harunor ^a   Inoue, Makoto ^a   Bakoshi, Shiho ^b   Ueda, Hiroshi ^a,c  

^a NAGASAKI UNIVERSITY   (Japan)

^b Maruishi Pharmaceutical Co Ltd   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CAPSAZEPINE; ONO 549187; PROSTACYCLIN DERIVATIVE; STREPTOZOCIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BITE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG ANTAGONISM; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LICKING; MALE; MOUSE; MYELINATED NERVE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; NONMYELINATED NERVE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SENSORY NERVE; STREPTOZOCIN DIABETES;

AFFERENT PATHWAYS; ANIMALS; CAPSAICIN; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; HEAT; HYPERALGESIA; INJECTIONS, INTRAVENOUS; MICE; NERVE FIBERS, MYELINATED; NEURONS, AFFERENT; PAIN; PHENOTYPE; RECEPTORS, DRUG; STREPTOZOCIN;

EID: 0038298197     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.050948     Document Type: Article

References (40)

1. Aley KO and Levine JD (2001) Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain 2:146-150.
2. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (Lond) 389:816-824.
3. Chen X and Levine JD (2001) Hyper-responsivity in a subset of C-fiber nociceptors in a model of painful diabetic neuropathy in the rat. Neuroscience 102:185-192.
4. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, and Di Marzo V (2001) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 77:1660-1663.
5. Di Marzo V, Blumberg PM, and Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12:372-379.
6. Dobretsov M, Hastings SL, Stimers JR, and Zhang JM (2001) Mechanical hyperalgesia in rats with chronic perfusion of lumbar dorsal root ganglion with hyperglycemic solution. J Neurosci Methods 110:9-15.
7. Franke FE, Schachenmayr W, Osborn M, and Altmannsberger M (1991) Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am J Pathol 139:67-79.
8. Hargreaves Y, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
9. Holzer P (1991) Capsaicin: cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol Rev 43:143-201.
10. Hiura A and Ishizuka H (1989) Changes in features of degenerating primary sensory neurons with time after capsaicin treatment. Acta Neuropathol 78:35-46.
11. Hudson LJ, Bevan S, Wotherspoon G, Gentry C, Fox A, and Winter J (2001) VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur J Neurosci 13:2105-2114.
12. Iguchi S, Miyata Y, Miyake H, Arai Y, Okegawa T, and Kawasaki A (1989) Synthesis of 15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20-pentanor-9-de oxy-6,9α-nitriloprostaglandin F1 methyl ester (OP-2507), a novel anti-cerebral ischemic agent. Adv Prostaglandin Thromboxane Leukot Res 19:670-673.
13. Inoue M, Rashid MH, Kawashima T, Matsumoto M, Maeda T, Kishioka S, and Ueda H (2003) The algogenic-induced nociceptive flexion test in mice: studies on sensitivity of the test and stress on animals. Brain Res Bull 60:275-281.
14. Inoue M, Shimohira I, Yoshida A, Zimmer A, Takeshima H, Sakurada T, and Ueda H (1999) Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord. J Pharmacol Exp Ther 291:308-313.
15. Jancso G, Kiraly E, and Jancso-Gabor A (1977) Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature (Lond) 270: 741-743.
16. Jancsó N and Jancsó A (1949) Desensitization of sensory nerve endings (in Hungarian). Kisérletes Orvostudomány 2 (Suppl):15.
17. Kamei J, Ohhashi Y, Aoki T, and Kasuya Y (1991) Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuli. Pharmacol Biochem Behav 39:541-544.
18. Kamei J, Zushida K, Morita K, Sasaki M, and Tanaka S (2001) Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice. Eur J Pharmacol 422:83-86.
19. Khan GM, Chen SR, and Pan HL (2002) Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 114:291-299.
20. Lee WT, Sohn MK, Park SH, Ahn SK, Lee JE, and Park KA (2001) Studies on the changes of c-fos protein in spinal cord and neurotransmitter in dorsal root ganglion of the rat with an experimental peripheral neuropathy. Yonsei Med J 42:30-40.
21. Low PA, Opfer-Gehrking TL, Dyck PJ, Litchy WJ, and O'Brien PC (1995) Double-blind, placebo-conrrolled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 62:163-168.
22. Malmberg AB and Basbaum AI (1998) Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 76: 215-222.
23. Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, Guo A, Blumberg PM, and Szallasi A (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1) and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 97:3655-3660.
24. Minami T, Bakoshi S, Nakano H, Mine O, Muratani T, Mori H, and Ito S (2001) The effects of capsaicin cream on prostaglandin-induced allodynia. Anesth Analg 93: 419-423.
25. Otten U, Lorez HP, and Businger F (1983) Nerve growth factor antagonizes the neurotoxic action of capsaicin on primary sensory neurones. Nature (Lond) 301: 515-517.
26. Premkumar LS and Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature (Lond) 408:985-990.
27. Rashid MH, Inoue M, Kondo S, Kawashima T, Bakoshi S, and Ueda H (2003) Novel expression of vanilloid receptor 1 (VR1) on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 304:940-948.
28. Rashid MH and Ueda H (2002) Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice. J Pharmacol Exp Ther 303:226-231.
29. Sakurada T, Katsumata K, Tan-No K, Sakurada S, and Kisara K (1992) The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 31:1279-1285.
30. Santos ARS and Calixto JB (1997) Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci Lett 235:73-76.
31. Schnedl WJ, Ferber S, Johnson JH, and Newgard CB (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43:1326-1333.
32. Sima AAF and Sugimoto K (1999) Experimental diabetic neuropathy: an update. Diabetologia 42:773-788.
33. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-211.
34. The Capsaicin Study Group (1991) Treatment of painful diabetic neuropathy with topical capsaicin. A multicentre, double-blind, vehicle-controlled study. Arch Intern Med 151:2225-2229.
35. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, and Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21:531-543.
36. Ueda H (1999) In vivo molecular signal transduction of peripheral mechanisms of pain. Jpn J Pharmacol 79:263-268.
37. Ueda H, Matsunaga S, Inoue M, Yamamoto Y, and Hazato T (2000) Complete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine. Peptides 21:1215-1221.
38. Valtschanoff JG, Rustioni A, Guo A, and Hwang SJ (2001) Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. J Comp Neurol 436:225-235.
39. Vellani V, Mapplebeck S, Moriondo A, Davis JB, and McNaughton PA (2001) Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. J Physiol (Lond) 534:813-825.
40. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.